Phase I/II trial of encorafenib, cetuximab, and nivolumab in patients with microsatellite stable (MSS), BRAF(V600E) metastatic colorectal cancer.

Morris, VK; Parseghian, CM; Escano, M; Johnson, B; Raghav, KPS; Dasari, A; Huey, R; Overman, MJ; Willis, J; Lee, MS; Wolff, RA; Kee, BK; Le, P; Margain, C; Gallup, D; Tam, A; Foo, WC; Xiao, LC; Yun, K; Kopetz, S

JOURNAL OF CLINICAL ONCOLOGY, 2022; 40 (16):

Abstract

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索